BIOMAT Database Logo BIOMAT Database Logo

Urinary metabolites of caffeine in pregnant women. 1986

N R Scott, and J Chakraborty, and V Marks

In a study of caffeine and its metabolites in pregnant and non-pregnant women, on average 56.8% of the administered caffeine dose was recovered in the urine in both groups. However, compared to the controls, the pregnant subjects produced smaller amounts of 1-methylxanthine and 1-methyluric acid, whereas the excretion of most of the other metabolites, particularly 3,7-dimethylxanthine and 3-methylxanthine tended to be greater. It is suggested that hormonal influences on the hepatic caffeine metabolising enzymes might be implicated.

UI MeSH Term Description Entries
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D002110 Caffeine A methylxanthine naturally occurring in some beverages and also used as a pharmacological agent. Caffeine's most notable pharmacological effect is as a central nervous system stimulant, increasing alertness and producing agitation. It also relaxes SMOOTH MUSCLE, stimulates CARDIAC MUSCLE, stimulates DIURESIS, and appears to be useful in the treatment of some types of headache. Several cellular actions of caffeine have been observed, but it is not entirely clear how each contributes to its pharmacological profile. Among the most important are inhibition of cyclic nucleotide PHOSPHODIESTERASES, antagonism of ADENOSINE RECEPTORS, and modulation of intracellular calcium handling. 1,3,7-Trimethylxanthine,Caffedrine,Coffeinum N,Coffeinum Purrum,Dexitac,Durvitan,No Doz,Percoffedrinol N,Percutaféine,Quick-Pep,Vivarin,Quick Pep,QuickPep
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013806 Theophylline A methyl xanthine derivative from tea with diuretic, smooth muscle relaxant, bronchial dilation, cardiac and central nervous system stimulant activities. Theophylline inhibits the 3',5'-CYCLIC NUCLEOTIDE PHOSPHODIESTERASE that degrades CYCLIC AMP thus potentiates the actions of agents that act through ADENYLYL CYCLASES and cyclic AMP. 1,3-Dimethylxanthine,3,7-Dihydro-1,3-dimethyl-1H-purine-2,6-dione,Accurbron,Aerobin,Aerolate,Afonilum Retard,Aquaphyllin,Armophylline,Bronchoparat,Bronkodyl,Constant-T,Elixophyllin,Euphylong,Glycine Theophyllinate,Lodrane,Monospan,Nuelin,Nuelin S.A.,Quibron T-SR,Slo-Phyllin,Somophyllin-T,Sustaire,Synophylate,Theo Von Ct,Theo-24,Theo-Dur,Theobid,Theocin,Theoconfin Continuous,Theodur,Theolair,Theolix,Theon,Theonite,Theopek,Theophylline Anhydrous,Theophylline Sodium Glycinate,Theospan,Theostat,Theovent,Uniphyl,Uniphyllin,Uniphylline,1,3 Dimethylxanthine,Anhydrous, Theophylline,Constant T,ConstantT,Ct, Theo Von,Glycinate, Theophylline Sodium,Quibron T SR,Quibron TSR,Slo Phyllin,SloPhyllin,Sodium Glycinate, Theophylline,Somophyllin T,SomophyllinT,Theo 24,Theo Dur,Theo24,Theophyllinate, Glycine,Von Ct, Theo
D014527 Uric Acid An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN. 2,6,8-Trihydroxypurine,Ammonium Acid Urate,Monosodium Urate,Monosodium Urate Monohydrate,Potassium Urate,Sodium Acid Urate,Sodium Acid Urate Monohydrate,Sodium Urate,Sodium Urate Monohydrate,Trioxopurine,Urate,Acid Urate, Ammonium,Acid Urate, Sodium,Acid, Uric,Monohydrate, Monosodium Urate,Monohydrate, Sodium Urate,Urate Monohydrate, Monosodium,Urate Monohydrate, Sodium,Urate, Ammonium Acid,Urate, Monosodium,Urate, Potassium,Urate, Sodium,Urate, Sodium Acid
D014970 Xanthines Purine bases found in body tissues and fluids and in some plants.

Related Publications

N R Scott, and J Chakraborty, and V Marks
Variability and predictors of urinary phthalate metabolites in Spanish pregnant women.
March 2015, International journal of hygiene and environmental health,
N R Scott, and J Chakraborty, and V Marks
Urinary metabolites of caffeine in young dogs.
January 1982, Drug metabolism and disposition: the biological fate of chemicals,
N R Scott, and J Chakraborty, and V Marks
Assessing caffeine exposure in pregnant women.
October 2008, The British journal of nutrition,
N R Scott, and J Chakraborty, and V Marks
Urinary metabolites of organophosphate flame retardants and their variability in pregnant women.
February 2014, Environment international,
N R Scott, and J Chakraborty, and V Marks
Urinary metabolites of caffeine in the premature infant.
January 1986, European journal of clinical pharmacology,
N R Scott, and J Chakraborty, and V Marks
Effects of smoking on caffeine urinary metabolites.
October 1991, Clinical pharmacology and therapeutics,
N R Scott, and J Chakraborty, and V Marks
Caffeine, coffee, and tea intake and urinary estrogens and estrogen metabolites in premenopausal women.
August 2015, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology,
N R Scott, and J Chakraborty, and V Marks
Should Pregnant Women Worry About Caffeine?
November 2016, Biological psychiatry,
N R Scott, and J Chakraborty, and V Marks
Association of urinary caffeine and caffeine metabolites with cardiovascular disease risk in adults.
April 2021, Nutrition (Burbank, Los Angeles County, Calif.),
N R Scott, and J Chakraborty, and V Marks
Associations of urinary caffeine and caffeine metabolites with metabolic syndrome in US adults.
January 2023, Frontiers in nutrition,
Copied contents to your clipboard!